J.D. has acted as a consultant and/or adviser of AmMax Bio, AstraZeneca, Baird Conferences, Genagon, Intellisphere LLC, Launchpad Therapeutics, MEDACorp and NuProbe, and has received research funding from AstraZeneca, BoltBio, Merck and Orum. S.M. has acted as an adviser and/or speaker for Boehringer Ingelheim, Daiichi-Sankyo, Duality Bio, Eli Lilly, Genentech, Pfizer and Seagen, and has received research funding from AstraZeneca, D3 bio, Daiichi-Sankyo, Duality Bio, Genentech, Nuvation bio, Pfizer and Seagen.